DNA CHIP FOR DIAGNOSIS OF CORNEAL DYSTROPHY
    23.
    发明申请
    DNA CHIP FOR DIAGNOSIS OF CORNEAL DYSTROPHY 审中-公开
    用于诊断角膜晶状体的DNA芯片

    公开(公告)号:US20090305394A1

    公开(公告)日:2009-12-10

    申请号:US12160965

    申请日:2007-01-18

    CPC classification number: C12Q1/6883 C12Q2600/156

    Abstract: The present invention relates to oligonucleotides for diagnosis of corneal dystrophy. More particularly, the present invention relates to oligonucleotides for detecting mutation of BIGH3 gene for diagnosis or corneal dystrophy including Avellino corneal dystrophy, which must be precisely diagnosed before vision correction surgery, and a DNA chip for diagnosis of corneal dystrophy, which has the oligonucleotides fixed thereon. According to the present invention, conventional microscopic diagnosis of corneal dystrophy can be replaced with a precise genetic method, which prevents a patient with corneal dystrophy from losing eyesight by eyesight correction surgery after erroneous diagnosis.

    Abstract translation: 本发明涉及用于诊断角膜营养不良的寡核苷酸。 更具体地,本发明涉及用于检测用于诊断或角膜营养不良的BIGH3基因的突变的寡核苷酸,其包括在视力矫正手术之前必须精确诊断的Avellino角膜营养不良,以及用于诊断角膜营养不良的DNA芯片,其具有固定的寡核苷酸 上。 根据本发明,可以用精确的遗传方法代替常规的角膜营养不良症的微观诊断,其可以防止角膜营养不良患者在错误诊断后通过视力矫正手术而失去视力。

    Method of Forming Metal Oxide and Apparatus for Performing the Same
    25.
    发明申请
    Method of Forming Metal Oxide and Apparatus for Performing the Same 有权
    形成金属氧化物的方法及其执行装置

    公开(公告)号:US20080056975A1

    公开(公告)日:2008-03-06

    申请号:US11775111

    申请日:2007-07-09

    CPC classification number: C01G25/02 C01G23/047 C01G27/02 C01G35/00 C01P2006/40

    Abstract: In a method and an apparatus for forming metal oxide on a substrate, a source gas including metal precursor flows along a surface of the substrate to form a metal precursor layer on the substrate. An oxidizing gas including ozone flows along a surface of the metal precursor layer to oxidize the metal precursor layer so that the metal oxide is formed on the substrate. A radio frequency power is applied to the oxidizing gas flowing along the surface of the metal precursor layer to accelerate a reaction between the metal precursor layer and the oxidizing gas. Acceleration of the oxidation reaction may improve electrical characteristics and uniformity of the metal oxide.

    Abstract translation: 在基板上形成金属氧化物的方法和装置中,包括金属前体的源气体沿着基板的表面流动,以在基板上形成金属前体层。 包括臭氧的氧化气体沿着金属前体层的表面流动,以氧化金属前体层,从而在基板上形成金属氧化物。 对沿着金属前体层的表面流动的氧化气体施加射频功率,以加速金属前体层与氧化气体的反应。 氧化反应的加速可以改善金属氧化物的电特性和均匀性。

    Agent for reduction of scar formation by using wound alkalinization
    27.
    发明授权
    Agent for reduction of scar formation by using wound alkalinization 失效
    通过使用伤口碱化来减少瘢痕形成的药剂

    公开(公告)号:US07255883B2

    公开(公告)日:2007-08-14

    申请号:US10312097

    申请日:2001-06-20

    CPC classification number: A61K33/00

    Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-β. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-β in a living organism.

    Abstract translation: 本发明涉及一种用于减少瘢痕形成的药剂,其通过用注射器将碳酸氢钠注入伤口的真皮组织来抑制瘢痕形成,以直接控制伤口部位的pH,即通过使伤口碱化以使TGF- 测试版 根据本发明,通过控制伤口愈合过程来减少瘢痕形成的药剂可以临床上立即应用于治疗泰乐菌瘢痕和瘢痕疙瘩等,对于治疗难治性纤维化疾病是有效的。 此外,本发明可以以许多方式广泛应用,作为可以控制活体中TGF-β的作用的简单工具。

Patent Agency Ranking